- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 117.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 117.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 117.89M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$163.48K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$138.61K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $162.05K |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $414.83K |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $908.05K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $908.05K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.41M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.41M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.41M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.41M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.58M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.82M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.52K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.13K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$252.79K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$223.92K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$177.98K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$157.82K |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |